Boosting Osimertinib Blood Brain Barrier Penetration

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Boosting Osimertinib Blood Brain Barrier Penetration	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 2	2026-06-05		NCT07485452

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AstraZeneca	806
Maastricht University Medical Center	157
The Netherlands Cancer Institute	113

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Maastricht UMC+	Maastricht	Netherlands	22
The Netherlands Cancer Institute	Amsterdam	Netherlands	6

Clinical trials